Characterization of side population cells in bone marrow of myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria.

骨髓增生异常综合征、再生障碍性贫血和阵发性睡眠性血红蛋白尿症骨髓中侧群细胞的特征。

基本信息

  • 批准号:
    16590945
  • 负责人:
  • 金额:
    $ 1.79万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

At first, we investigated frequency of side population (SP) cells in bone marrow (BM) mononuclear cells (MNC) of clinical cases with myelodysplastic syndrome (MDS : 24 cases), aplastic anemia (AA : 5 cases), and paroxysmal nocturnal hemoglobinuria (PNH : 3 cases). Mean values of SP cell population in MDS, AA, PNH, and healthy BM were 0.62%, 0.006%, 0.42%, and 0.23%, respectively. There was no significance in these frequencies between MDS, PNH, and healthy BM. With regard to WHO subtypes of MDS, we could detect the frequency of SP cells as follows ; RA 0-1.41%, RARS 0.03-0.57%, RCMD 0.11-2.04%, RAEB1 1.18-2.63%, and RAEB2 3.11% (one case). Next, to confirm clonality of SP cells in MDS samples, we sorted SP cells from two cases with trisomy 8 and one case of monosomy 7 by FACS cell sorter, and investigated their recurrent chromosomal abnormalities, which were observed in original samples, by fluorescence in situ hybridization (FISH). In all three cases, it was indicated that SP cell popu … More lation involved abnormal clones. Concurrently, expression of ABCG2 protein in BMMNC was tested. Mean values of ABCG2+ cells in BMMNC of MDS, AA, and PNH were 3.73%, 0.01%, and 1.99%, respectively. Results of ABCG2 expression analysis by FACS were more stable and indicated less difference in each sample and examination than those of SP cell assay. By multi-marker analysis by FACS, it was indicated that the population of SP cells and ABCG2+ cells of MDS and PNH expressed CD34 or CD133 simultaneously, but didn't expressed surface markers of more differentiated hematopopietic cells (CD19, CD3, and CD33). Therefore, to investigate properties of SP cells and ABCG2+ cells as hematopoietic stem cells (HSC), we applied long-term culture-initiated cells (LTC-IC) assay and cobblestone area forming cells (CAFC) assay to these populations. In AA cases, both LTC-IC and CAFC were markedly reduced. In MDS and PNH cases, the frequencies of LTC-IC and CAFC were lower than healthy BM. Furthermore, in MDS cases, cell numbers forming each CA were less than in healthy BM, and CAs in MDS samples were regressed earlier (in 3-5 weeks) than in healthy BM samples (5-7 weeks) by same stimulatory condition of growth factors. Taken together, quantitative and functional abnormalities of HSC in MDS/AA/PNH were indicated through the analysis of SP cell and ABCG+ cell populations. Less
首先,我们研究了骨髓增生异常综合征(MDS: 24例)、再生障碍性贫血(AA: 5例)和阵发性夜间血红蛋白尿(PNH: 3例)患者骨髓(BM)单核细胞(MNC)侧群(SP)细胞的频率。MDS、AA、PNH和健康BM的SP细胞群平均值分别为0.62%、0.006%、0.42%和0.23%。这些频率在MDS、PNH和健康BM之间没有显著性差异。对于MDS的WHO亚型,我们可以检测到SP细胞的频率如下:RA 0 ~ 1.41%, RARS 0.03 ~ 0.57%, RCMD 0.11 ~ 2.04%, RAEB1 1.18 ~ 2.63%, RAEB2 3.11%(1例)。接下来,为了确认MDS样本中SP细胞的克隆性,我们利用FACS细胞分选器对2例8三体和1例7单体的SP细胞进行了分选,并利用荧光原位杂交(FISH)对其在原始样本中观察到的复发性染色体异常进行了研究。在这三种情况下,都表明SP细胞的增殖与异常克隆有关。同时检测ABCG2蛋白在BMMNC中的表达。MDS、AA和PNH患者BMMNC中ABCG2+细胞的平均值分别为3.73%、0.01%和1.99%。与SP细胞法相比,FACS法测定的ABCG2表达结果更稳定,且各样品和各检查结果差异较小。通过FACS多标记分析发现,MDS和PNH的SP细胞和ABCG2+细胞群体同时表达CD34或CD133,但未表达分化程度更高的造血细胞表面标记(CD19、CD3和CD33)。因此,为了研究SP细胞和ABCG2+细胞作为造血干细胞(HSC)的特性,我们对这些群体应用了长期培养启动细胞(LTC-IC)实验和鹅卵石区域形成细胞(CAFC)实验。AA组LTC-IC和CAFC均明显降低。在MDS和PNH病例中,LTC-IC和CAFC的频率低于健康BM。此外,在MDS病例中,形成每个CA的细胞数量少于健康BM,并且在相同的生长因子刺激条件下,MDS样本中的CA比健康BM样本(5-7周)更早(3-5周)回归。综上所述,通过对SP细胞和ABCG+细胞群的分析,表明MDS/AA/PNH中HSC的数量和功能异常。少

项目成果

期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
DNA microarray analysis of dysplastic morphology associated with acute myeloid leukemia.
与急性髓系白血病相关的发育不良形态的 DNA 微阵列分析。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Numata;A.;Shimoda;K.;Kamezaki;K.;Haro;T.;Kakumitsu;H.;Shide;K.;Kato;K.;Miyamoto;T.;Yamashita;Y.;Oshima;Y.;Nakajima;H.;Iwama;A.;Aoki;K.;Takase;K.;Gondo;H.;Mano;H.;Harada;M.;He H.et al.;Kaneda R. et al.;Tsutsumi C. et al.
  • 通讯作者:
    Tsutsumi C. et al.
Proviral status of HTLV-1 integrated into the host genomic DNA of adult T-cell leukemia cells
  • DOI:
    10.1111/j.1365-2257.2005.00698.x
  • 发表时间:
    2005-08-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kamihira, S;Sugahara, K;Yamada, Y
  • 通讯作者:
    Yamada, Y
The Second Nagasaki Symposium of International Consortium for Medical Care of Hibakusha and Radiation Life Science.
国际原子弹爆炸幸存者医疗与辐射生命科学联盟第二届长崎研讨会。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nagai K;Miyazaki Y;Tomonaga M;et al.
  • 通讯作者:
    et al.
Difference in clinical features between Japanese and German patient with refractory anemia in myelodysplastic syndromes.
日本和德国难治性贫血骨髓增生异常综合征患者临床特征的差异。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Akira Matsuda;et al.
  • 通讯作者:
    et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAGAI Kazuhiro其他文献

NAGAI Kazuhiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAGAI Kazuhiro', 18)}}的其他基金

Comprehensive influence on tumor immune system by interaction between pancreatic cancer and molecules of tumor microenvironment.
胰腺癌与肿瘤微环境分子相互作用对肿瘤免疫系统的综合影响。
  • 批准号:
    15K10190
  • 财政年份:
    2015
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Adhesion-dependent growth of ATL cells ; significance of signaling pathway through adhesion molecules
ATL细胞的粘附依赖性生长;
  • 批准号:
    12670992
  • 财政年份:
    2000
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Engineering the bone marrow niche to control stem cell regulation, metastatic evolution and cancer dormancy
改造骨髓生态位来控制干细胞调节、转移进化和癌症休眠
  • 批准号:
    EP/X036049/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Research Grant
Tuning tyrosine kinase signalling to improve haematopoietic stem cell expansion and bone marrow transplantation
调节酪氨酸激酶信号传导以改善造血干细胞扩增和骨髓移植
  • 批准号:
    2889841
  • 财政年份:
    2023
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Studentship
Rejuvenation of the Aged Bone Marrow Niche Restores Hematopoietic Stem Cell Function for Cardiac Repair and Regeneration
老化骨髓生态位的复兴恢复造血干细胞功能,促进心脏修复和再生
  • 批准号:
    478727
  • 财政年份:
    2023
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Operating Grants
Bone marrow mesenchymal stem cell transplantation prevents concurrent progression of chronic kidney disease and associated cerebrovascular disease
骨髓间充质干细胞移植可预防慢性肾病和相关脑血管疾病的并发进展
  • 批准号:
    23K08095
  • 财政年份:
    2023
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanism of hematopoietic stem cell homing by bone marrow nociceptive nerves and development of technology to improve the engraftment
阐明骨髓伤害性神经使造血干细胞归巢的机制并开发改善移植的技术
  • 批准号:
    23K19626
  • 财政年份:
    2023
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Tissue Engineering of 3D bone marrow niche for hematopoietic stem cells vs acute myeloid leukemia stem cell molecular target and therapeutics discovery
造血干细胞 3D 骨髓生态位的组织工程与急性髓系白血病干细胞分子靶标和治疗发现
  • 批准号:
    468535
  • 财政年份:
    2022
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Operating Grants
Preclinical development of a nuclear-targeting biologic that safely increases stem cell expansion in vivo to accelerate recovery from neutropenia after chemotherapy and bone marrow transplant
临床前开发一种核靶向生物制剂,可安全地增加干细胞体内扩增,以加速化疗和骨髓移植后中性粒细胞减少症的恢复
  • 批准号:
    10685290
  • 财政年份:
    2022
  • 资助金额:
    $ 1.79万
  • 项目类别:
Mechanism of malaria-induced disruption of hematopoietic stem cell niche in the bone marrow
疟疾引起骨髓造血干细胞生态位破坏的机制
  • 批准号:
    22K15448
  • 财政年份:
    2022
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Functional analysis of renal regeneration molecular mechanism by bone marrow mesenchymal stem cell transplantation for fibrosis after renal injury
骨髓间充质干细胞移植治疗肾损伤后纤维化肾再生分子机制的功能分析
  • 批准号:
    22K07939
  • 财政年份:
    2022
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Preventive and Therapeutic Effects of Bone Marrow Stem Cell-Derived Exosomes on Spine Dural Fibrosis
骨髓干细胞源性外泌体对脊柱硬膜纤维化的预防和治疗作用
  • 批准号:
    10350148
  • 财政年份:
    2022
  • 资助金额:
    $ 1.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了